Oncorus News

ONCRDelisted Stock  USD 0.04  0.01  14.71%   
Slightly above 62% of Oncorus' investor base is looking to short. The analysis of current outlook of investing in Oncorus suggests that many traders are alarmed regarding Oncorus' prospects. Oncorus' investing sentiment overview a quick insight into current market opportunities from investing in Oncorus. Many technical investors use Oncorus stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
over a year ago at news.google.com         
Phio Pharma rises 11 percent on positive data from preclinical study of PH ... - Seeking Alpha
Google News at Macroaxis
over a year ago at globenewswire.com         
Oncorus Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
Macroaxis News: globenewswire.com
over a year ago at investing.com         
Oncorus earnings missed by 0.12, revenue was in line with estimates
Investing News at Macroaxis
over a year ago at news.google.com         
Oncorus, Inc. Stock Price Today, Quote News - Seeking Alpha
Google News at Macroaxis
over a year ago at news.google.com         
Citi Trends Inc reports results for the quarter ended in January ... - Kalkine Media
Google News at Macroaxis
over a year ago at news.google.com         
SVB Had 86 Publicly Traded Customers Including BUZZ, ASTR ... - Bloomberg
Google News at Macroaxis
over a year ago at news.google.com         
Oncorus Inc - Has Regained Access To All Of Its Funds That Were ... - Kalkine Media
Google News at Macroaxis
over a year ago at news.google.com         
Biotech, med-tech exposure to US bank failures limited - BioWorld Online
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Critical Comparison Amarillo Biosciences versus Oncorus
news
over a year ago at news.google.com         
APTX stock falls as Phase 2 trial for Parkinsons disease and ... - Seeking Alpha
Google News at Macroaxis
over a year ago at news.google.com         
CHI Advisors Increases Position in Oncorus - Nasdaq
Google News at Macroaxis
over a year ago at Macroaxis         
Does Oncorus (NASDAQ:ONCR) have invariable basic indicators based on the latest spike?
Macroaxis News
Far too much social signal, news, headlines, and media speculation about Oncorus that are available to investors today. That information is available publicly through Oncorus media outlets and privately through word of mouth or via Oncorus internal channels. However, regardless of the origin, that massive amount of Oncorus data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Oncorus news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Oncorus relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Oncorus' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Oncorus alpha.

Oncorus Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Phio Pharma rises 11 percent on positive data from preclinical study of PH ... - Seeking Alpha
04/17/2023
2
Oncorus Reports First Quarter 2023 Financial Results and Provides ... - Marketscreener.com
05/22/2023
3
Oncorus Shares Head for All-Time Low on Cash Flow Concerns
06/02/2023
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Consideration for investing in Oncorus Stock

If you are still planning to invest in Oncorus check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oncorus' history and understand the potential risks before investing.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Fundamental Analysis
View fundamental data based on most recent published financial statements
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules